Activating killer immunoglobulin-like receptors genes are associated with increased susceptibility to ankylosing spondylitis

Clinical and Experimental Immunology

Volumn 180, Issue 2, 2015, Pages 201-206

  Diaz Pena R ^a,d   Vidal Castineira J R ^a   Mulero, J ^b   Sanchez A ^b   Queiro, R ^a   Lopez Larrea C ^a,c  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^b HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^c Section of Nephrology   (Spain)

^d UNIVERSIDAD AUTÓNOMA DE CHILE   (Chile)

Author keywords

Ankylosing spondylitis; HLA B27; KIR; Susceptibility

Indexed keywords

KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL2; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL3; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL4; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL5; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DS1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DS2; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DS3; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DS4; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DS5; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DS1; UNCLASSIFIED DRUG; HLA B27 ANTIGEN; KIR2DS1 PROTEIN, HUMAN;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE PREDISPOSITION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENOTYPE; HAPLOTYPE; HUMAN; IMMUNOPATHOGENESIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SPAIN; CLINICAL TRIAL; FEMALE; GENETICS; GENOTYPING TECHNIQUE; IMMUNOLOGY; MALE; MULTICENTER STUDY; PATHOLOGY;

FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GENOTYPING TECHNIQUES; HLA-B27 ANTIGEN; HUMANS; MALE; RECEPTORS, KIR; RECEPTORS, KIR3DS1; SPONDYLITIS, ANKYLOSING;

EID: 84927586517     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12568     Document Type: Article

References (27)

1. Brown MA, Kennedy LG, MacGregor AJ etal. Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment. Arthritis Rheum 1997; 40:1823-1828.
2. Thomas GP, Brown MA. Genetics and genomics of ankylosing spondylitis. Immunol Rev 2010; 233:162-180.
3. Gonzalez-Roces S, Alvarez MV, Gonzalez S etal. HLA-B27 polymorphism and worldwide susceptibility to ankylosing spondylitis. Tissue Antigens 1997; 49:116-123.
4. DeLay ML, Turner MJ, Klenk EI, Smith JA, Sowders DP, Colbert RA. HLA-B27 misfolding and the unfolded protein response augment interleukin-23 production and are associated with Th17 activation in transgenic rats. Arthritis Rheum 2009; 60:2633-2643.
5. Laval SH, Timms A, Edwards S etal. Whole-genome screening in ankylosing spondylitis: evidence of non-MHC genetic-susceptibility loci. Am J Hum Genet 2001; 68:918-926.
6. Khakoo SI, Carrington M. KIR and disease: a model system or system of models? Immunol Rev 2006; 214:186-201.
7. Díaz-Peña R, Blanco-Gelaz MA, López-Larrea C. KIR genes and their role in spondyloarthropathies. Adv Exp Med Biol 2009; 649:286-299.
8. Espeli M, Niederer HA, Traherne JA, Trowsdale J, Smith KG. Genetic variation, Fcγ receptors, KIRs and infection: the evolution of autoimmunity. Curr Opin Immunol 2010; 22:715-722.
9. Díaz-Peña R, Blanco-Gelaz MA, Suárez-Alvarez B etal. Activating KIR genes are associated with ankylosing spondylitis in Asian populations. Hum Immunol 2008; 69:437-442.
10. Jiao YL, Ma CY, Wang LC etal. Polymorphisms of KIRs gene and HLA-C alleles in patients with ankylosing spondylitis: possible association with susceptibility to the disease. J Clin Immunol 2008; 28:343-349.
11. Lopez-Larrea C, Blanco-Gelaz MA, Torre-Alonso JC etal. Contribution of KIR3DL1/3DS1 to ankylosing spondylitis in human leukocyte antigen-B27 Caucasian populations. Arthritis Res Ther 2006; 8:R101.
12. Díaz-Peña R, Vidal-Castiñeira JR, Alonso-Arias R etal. Association of the KIR3DS1*013 and KIR3DL1*004 alleles with susceptibility to ankylosing spondylitis. Arthritis Rheum 2010; 62:1000-1006.
13. Harvey D, Pointon JJ, Sleator C etal. Analysis of killer immunoglobulin-like receptor genes in ankylosing spondylitis. Ann Rheum Dis 2009; 68:595-598.
14. McCappin J, Harvey D, Wordsworth BP, Middleton D. No association of KIR3DL1 or KIR3DS1 or their alleles with ankylosing spondylitis. Tissue Antigens 2010; 75:68-73.
15. Jiao YL, Zhang BC, You L etal. Polymorphisms of KIR gene and HLA-C alleles: possible association with susceptibility to HLA-B27-positive patients with ankylosing spondylitis. J Clin Immunol 2010; 30:840-844.
16. Kollnberger S, Bowness P. The role of B27 heavy chain dimer immune receptor interactions in spondyloarthritis. Adv Exp Med Biol 2009; 649:277-285.
17. Van de Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984; 27:361-368.
18. Zuo HN, Wang ZL, Cui DR, Xin DJ. Genetic variations in the KIR gene family may contribute to susceptibility to ankylosing spondylitis: a meta-analysis. Mol Biol Rep 2014; 41:5311-5319.
19. Yu J, Heller G, Chewning J, Kim S, Yokoyama WM, Hsu KC. Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands. J Immunol 2007; 179:5977-5989.
20. Martin MP, Nelson G, Lee JH etal. Cutting edge: susceptibility to psoriatic arthritis: influence of activating killer Ig-like receptor genes in the absence of specific HLA-C alleles. J Immunol 2002; 169:2818-2822.
21. Tajik N, Shahsavar F, Poormoghim H, Radjabzadeh MF, Mousavi T, Jalali A. KIR3DL1+HLA-B Bw4Ile80 and KIR2DS1+HLA-C2 combinations are both associated with ankylosing spondylitis in the Iranian population. Int J Immunogenet 2011; 38:403-409.
22. Zvyagin IV, Mamedov IZ, Britanova OV etal. Contribution of functional KIR3DL1 to ankylosing spondylitis. Cell Mol Immunol 2010; 7:471-476.
23. Suzuki Y, Hamamoto Y, Ogasawara Y etal. Genetic polymorphisms of killer cell immunoglobulin-like receptors are associated with susceptibility to psoriasis vulgaris. J Invest Dermatol 2004; 122:1133-1136.
24. Santin I, Castellanos-Rubio A, Perez de Nanclares G, Vitoria JC, Castaño L, Bilbao JR. Association of KIR2DL5B gene with celiac disease supports the susceptibility locus on 19q13.4. Genes Immun 2007; 8:171-176.
25. Kimoto Y, Horiuchi T, Tsukamoto H etal. Association of killer cell immunoglobulin-like receptor 2DL5 with systemic lupus erythematosus and accompanying infections. Rheumatology (Oxf) 2010; 49:1346-1353.
26. García-León JA, Pinto-Medel MJ, García-Trujillo L etal. Killer cell immunoglobulin-like receptor genes in Spanish multiple sclerosis patients. Mol Immunol 2011; 48:1896-1902.
27. Wang S, Li G, Ge R etal. Association of KIR genotype with susceptibility to HLA-B27-positive ankylosing spondylitis. Mod Rheumatol 2013; 23:538-541.